2020년 초 비공개 회의에서 중국 고위 보건 당국자들이 “우한의 신종 코로나바이러스”에 대해 미국 보건당국에 브리핑하겠다고 제안했다고 새로 입수한 이메일에서  밝혀졌다.

미국과 전 세계 보건 당국이 중국에서 발생하는 신종 코로나바이러스 감염증(COVID-19) 발병에 대응하기 위해 분주하게 움직이고 있는 가운데 중국 질병통제예방센터(CDC)의 수석 고문인 랜스 로드왈드(Lance Rodewald)는 새로운 질병에 관한 "비공식 토론"을 제안했다고 함.

Top Chinese health officials offered to brief U.S. counterparts on the “new coronavirus in Wuhan” in a closed-door meeting in early 2020, newly obtained emails show.

As health officials in the United States and around the world were scrambling to respond to the emerging COVID-19 outbreak from China, Lance Rodewald, a senior adviser to the Chinese Center for Disease Control and Prevention (China CDC), floated an offer to have an “informal discussion” regarding the new illness.

“I’m writing to explore whether you may be interested in an informal presentation/briefing/discussion about the novel coronavirus by Dr. Feng Zijian at a side meeting around the time of the February ACIP meeting,” he said in an email dated Jan. 23, 2020, sent to eight U.S. Center for Disease Control and Prevention (CDC) officials.

ACIP is a panel of health experts that advises the CDC on vaccine recommendations. The panel typically meets at the CDC headquarters in Atlanta, Georgia.

The same day Rodewald made the offer, the Chinese city of Wuhan, where the CCP (Chinese Communist Party) virus first originated, entered into a full lockdown. The virus had been spreading in the city and around the world undetected as the Chinese regime suppressed crucial information about the outbreak and delayed acknowledging for weeks that the virus could transmit among humans.

The regime was also stonewalling repeated U.S. requests to send experts into China and get on-the-ground data.

Feng was the deputy director for the Chinese CDC at the time. He and Ma Chao, an official with China CDC’s National Immunization Program, were preparing to visit Atlanta for another conference, Rodewald told CDC officials in the email.

“I think that most of you know Dr. Feng Zijian,” he wrote, describing Feng as the architect of China’s National Immunization Advisory Committee. Feng “has visited US CDC many times, including for 6 months during the H1N1 influenza pandemic and in 2016 during an ACIP meeting,” he said.

Feng was leading China’s investigation into and response to the Wuhan virus, Rodewald said. “As such, he knows pretty-much everything about the investigation and response, including the virology, epidemiology, clinical spectrum, and mitigation measures being taken over here.”